Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class I · High risk

Tegsedi (inotersen)

Superpotent: High Out of specification (OOS) test result for percent label claim (%LC).

Terminated Wrong potency / content Akcea Therapeutics, Inc. D-1166-2022
Class III · Low risk

Alprostadil Injection USP 500 mcg/mL

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Terminated Impurity / degradation Teva Pharmaceuticals USA Inc NDC 0703-1501-02 D-0988-2022

Recalls by year